BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 637676)

  • 21. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A; Zoch-Zwierz W; Tomaszewska B; Tenderenda E
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defect in urinary acidification in nephrotic syndrome and its correction by furosemide.
    Rodriguez-Soriano J; Vallo A; Castillo G; Oliveros R
    Nephron; 1982; 32(4):308-13. PubMed ID: 7167208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encephalopathy after furosemide use in nephrotic syndrome.
    Sharma AP; Grimmer J
    J Paediatr Child Health; 2007 Mar; 43(3):188-90. PubMed ID: 17316196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.
    Green TP; Mirkin BL
    J Pharmacol Exp Ther; 1981 Jul; 218(1):122-7. PubMed ID: 7241373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?
    Na KY; Han JS; Kim YS; Ahn C; Kim S; Lee JS; Bae KS; Jang IJ; Shin SG; Huh W; Jeon US
    J Korean Med Sci; 2001 Aug; 16(4):448-54. PubMed ID: 11511790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences with high doses of furosemide in renal disease and resistant edematous states.
    Silverberg DS; Ulan RA; Baltzan MA; Baltzan RB
    Can Med Assoc J; 1970 Jul; 103(2):129-33. PubMed ID: 5430050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal failure with nephrotic syndrome: reversal with large doses of furosemide.
    Sakemi T; Uchida M; Baba N; Nagano Y; Shimokama T; Watanabe T
    Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):59-64. PubMed ID: 2038133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
    Salomon R; Gagnadoux MF; Niaudet P
    Transplantation; 2003 Mar; 75(6):810-4. PubMed ID: 12660507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of furosemide on water and sodium excretion in apparently normal infants].
    López Uriarte A; Sánchez Burgos J; Santos Atherton D
    Bol Med Hosp Infant Mex; 1976; 33(3):693-8. PubMed ID: 1275971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of albumin infusion upon plasma norepinephrine concentration in nephrotic children.
    Kelsch RC; Light GS; Oliver WJ
    J Lab Clin Med; 1972 Apr; 79(4):516-25. PubMed ID: 5021294
    [No Abstract]   [Full Text] [Related]  

  • 33. Population pharmacokinetic study of cyclosporine in patients with nephrotic syndrome.
    Xiaoli D; Qiang F
    J Clin Pharmacol; 2009 Jul; 49(7):782-8. PubMed ID: 19448042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Furosemide at high doses in a girl with chronic renal failure].
    López Uriarte A; Maldonado Martínez E
    Bol Med Hosp Infant Mex; 1978; 35(3):523-7. PubMed ID: 629840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
    Sjöström P
    Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of severe nephrotic edema with albumin and furosemide.
    Weiss RA; Schoeneman M; Greifer I
    N Y State J Med; 1984 Aug; 84(8):384-6. PubMed ID: 6592472
    [No Abstract]   [Full Text] [Related]  

  • 37. Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A.
    Wasilewska A; Zoch-Zwierz W; Tenderenda E
    Acta Paediatr; 2006 Mar; 95(3):291-6. PubMed ID: 16497638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Furosemide binding to human albumin and plasma of nephrotic children.
    Prandota J; Pruitt AW
    Clin Pharmacol Ther; 1975 Feb; 17(2):159-65. PubMed ID: 235396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.